These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 18323166

  • 1. Quantitative analysis of survivin mRNA expression in bladder transitional cell carcinomas.
    Kitsukawa S, Aoyagi T, Noda K, Ito T, Yamamoto Y, Hosoda S, Otsuru N, Matsumoto T.
    Hinyokika Kiyo; 2008 Feb; 54(2):101-6. PubMed ID: 18323166
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Survivin expression is associated with bladder cancer presence, stage, progression, and mortality.
    Shariat SF, Ashfaq R, Karakiewicz PI, Saeedi O, Sagalowsky AI, Lotan Y.
    Cancer; 2007 Mar 15; 109(6):1106-13. PubMed ID: 17311310
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
    Christoph F, Müller M, Schostak M, Soong R, Tabiti K, Miller K.
    Urology; 2004 Jul 15; 64(1):157-61. PubMed ID: 15245962
    [Abstract] [Full Text] [Related]

  • 7. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.
    Nouraee N, Mowla SJ, Ozhand A, Parvin M, Ziaee SA, Hatefi N.
    Urol J; 2009 Jul 15; 6(2):101-8. PubMed ID: 19472128
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer.
    Moussa O, Abol-Enein H, Bissada NK, Keane T, Ghoneim MA, Watson DK.
    J Urol; 2006 Jun 15; 175(6):2312-6. PubMed ID: 16697865
    [Abstract] [Full Text] [Related]

  • 9. Effect of intravesical treatment of transitional cell carcinoma with bacillus Calmette-Guerin and mitomycin C on urinary survivin levels and outcome.
    Hausladen DA, Wheeler MA, Altieri DC, Colberg JW, Weiss RM.
    J Urol; 2003 Jul 15; 170(1):230-4. PubMed ID: 12796695
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prostate stem cell antigen predicts tumour recurrence in superficial transitional cell carcinoma of the urinary bladder.
    Elsamman E, Fukumori T, Kasai T, Nakatsuji H, Nishitani MA, Toida K, Ali N, Kanayama HO.
    BJU Int; 2006 Jun 15; 97(6):1202-7. PubMed ID: 16686711
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. P21-activated kinase 1: a new molecular marker for intravesical recurrence after transurethral resection of bladder cancer.
    Ito M, Nishiyama H, Kawanishi H, Matsui S, Guilford P, Reeve A, Ogawa O.
    J Urol; 2007 Sep 15; 178(3 Pt 1):1073-9. PubMed ID: 17644138
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Urinary cytokeratin 20 mRNA expression has the potential to predict recurrence in superficial transitional cell carcinoma of the bladder.
    Christoph F, Weikert S, Wolff I, Schostak M, Tabiti K, Müller M, Miller K, Schrader M.
    Cancer Lett; 2007 Jan 08; 245(1-2):121-6. PubMed ID: 16473461
    [Abstract] [Full Text] [Related]

  • 17. Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer.
    Boorjian S, Ugras S, Mongan NP, Gudas LJ, You X, Tickoo SK, Scherr DS.
    Urology; 2004 Aug 08; 64(2):383-8. PubMed ID: 15302512
    [Abstract] [Full Text] [Related]

  • 18. Urinary survivin mRNA expression and urinary nuclear matrix protein 22 BladderChek® and urine cytology in the detection of transitional cell carcinoma of the bladder.
    Al-Maghrebi M, Kehinde EO, Kapila K, Anim JT.
    Med Princ Pract; 2012 Aug 08; 21(3):295-7. PubMed ID: 22236881
    [Abstract] [Full Text] [Related]

  • 19. Analysis of hTERT expression in exfoliated cells from patients with bladder transitional cell carcinomas using SYBR green real-time fluorescence quantitative PCR.
    Xie XY, Yang X, Zhang JH, Liu ZJ.
    Ann Clin Biochem; 2007 Nov 08; 44(Pt 6):523-8. PubMed ID: 17961306
    [Abstract] [Full Text] [Related]

  • 20. Primary application study in early diagnosis of bladder cancer by survivin molecular beacons.
    Zhao J, He D, He H, Li L, Zhang LL, Wang XY.
    Urology; 2007 Jul 08; 70(1):60-4. PubMed ID: 17656209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.